Arterial Thromboembolism Clinical Trials
2 recruiting trials for Arterial Thromboembolism. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Arterial Thromboembolism clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Imperative Care, Inc. (1), Peking University People's Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Symphony Thrombectomy System (device, 2 trials), followed by Prodigy Thrombectomy System.
Track Arterial Thromboembolism trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Aspiration Thrombectomy Using the Symphony or Prodigy System
The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures...
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Arterial Thromboembolism, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Arterial Thromboembolism, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Arterial Thromboembolism, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.